Clinical outcomes, local-regional control and the role for metastasis-directed therapies in stage III non-small cell lung cancers treated with chemoradiation and durvalumab

BACKGROUND AND PURPOSE: Concurrent chemoradiation (cCRT) and durvalumab is standard therapy for patients with unresectable stage III non-small-cell lung cancers (NSCLC). Data is limited on outcomes with this regimen outside of clinical trials. Local-regional control rates remain undefined. MATERIALS...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Radiother Oncol
Главные авторы: Offin, Michael, Shaverdian, Narek, Rimner, Andreas, Lobaugh, Stephanie, Shepherd, Annemarie F., Simone, Charles B., Gelblum, Daphna Y., Wu, Abraham J., Lee, Nancy, Kris, Mark G., Rudin, Charles M., Zhang, Zhigang, Hellmann, Matthew D., Chaft, Jamie E., Gomez, Daniel R.
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8239428/
https://ncbi.nlm.nih.gov/pubmed/32361014
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2020.04.047
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы